Literature DB >> 2560617

Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma.

G R Krueger1, M Manak, N Bourgeois, D V Ablashi, S Z Salahuddin, S S Josephs, A Buchbinder, R C Gallo, F Berthold, H Tesch.   

Abstract

This study focuses on lymphoproliferative diseases associated with persistent infection by Epstein-Barr virus (EBV) and human herpes virus 6 (HHV-6). A suggestive premalignant lymphoproliferative state is distinguished from malignant lymphoma and identified as "atypical polyclonal lymphoproliferation" (APL). Sixteen cases of herpes virus (HHV)-associated APL are compared with 21 cases of HHV-associated malignant lymphomas (ML), with 108 cases of EBV or HHV-6 related acute infections mononucleosis, with 14 cases of seronegative non-specific lymphoid hyperplasia and with 304 cases of HHV-unrelated ML. Six cases of APL and two ML occurred in AIDS patients, two cases in Sjogren's syndrome, one in a kidney allograft recipient, and the remaining cases had no identified underlying disease. APL was histologically reminiscient of excessive infectious mononucleosis, while other cases of Castleman's disease or even of malignant lymphoma. Seropositive APL and ML contained significantly more virus genome than is found in latent background infection. There was no histologic difference between HHV-6 or EBV-positive APL or ML, although both viruses infect different lymphocyte populations. From histology alone, seropositive ML cases were not distinguished from seronegative ones, yet persistent active EBV and HHV-6 appear to predominate in follicular center cell- and immunoblastic lymphoma and in HOdgkin's disease. Although no a direct oncogenic activity of these viruses could be observed in our cases, they may contribute to lymphomagenesis by inducing progressive lymphoproliferation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2560617

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction.

Authors:  P Sola; E Merelli; R Marasca; M Poggi; M Luppi; M Montorsi; G Torelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

3.  Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.

Authors:  L Flamand; J Gosselin; M D'Addario; J Hiscott; D V Ablashi; R C Gallo; J Menezes
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Structure and transcription of an immediate-early region in the human herpesvirus 6 genome.

Authors:  U Schiewe; F Neipel; D Schreiner; B Fleckenstein
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

5.  Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.

Authors:  L Flamand; I Stefanescu; D V Ablashi; J Menezes
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

6.  A chronic "postinfectious" fatigue syndrome associated with benign lymphoproliferation, B-cell proliferation, and active replication of human herpesvirus-6.

Authors:  D Buchwald; A S Freedman; D V Ablashi; J L Sullivan; M Caligiuri; D S Weinberg; C G Hall; R L Ashley; C Saxinger; N Balachandran
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

7.  Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection.

Authors:  Samah A Loutfy; Mohamed Fawzy; Mohamed El-Wakil; Manar M Moneer
Journal:  Virol J       Date:  2010-10-27       Impact factor: 4.099

Review 8.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

Review 9.  Lymphoproliferative Syndromes Associated with Human Herpesvirus-6A and Human Herpesvirus-6B.

Authors:  Eva Eliassen; Gerhard Krueger; Mario Luppi; Dharam Ablashi
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.